Sodicta, Meriam .

HRN: 15-36-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/03/2026
05/04/2026
IV
400
Q8
SP LTCS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: